Skip to main content
. Author manuscript; available in PMC: 2012 Sep 22.
Published in final edited form as: Adv Mater. 2011 Aug 15;23(36):H217–H247. doi: 10.1002/adma.201102313

Figure 1.

Figure 1

Typical nanomaterial formulations for imaging and therapy of cancers, their mechanism for imaging, and associated representative images. Example images reproduced with permission for liposomes and micelles (SPECT image overlaid with CT),[15] polymers and dendrimers (PET image overlaid with CT),[275] noble metals (near-IR optical imaging),[276] semiconductors (fluorescence imaging),[32] carbon nanotubes and fullerenes (photoacoustic imaging),[35] transition metal oxides (MRI),[81] metal-organic frameworks (MRI),[51] and lanthanide series (X-ray radioluminescence imaging).[57]